PE20180413A1 - Composicion efervescente en forma solida que comprende cepas bacterianas probioticas - Google Patents

Composicion efervescente en forma solida que comprende cepas bacterianas probioticas

Info

Publication number
PE20180413A1
PE20180413A1 PE2018000014A PE2018000014A PE20180413A1 PE 20180413 A1 PE20180413 A1 PE 20180413A1 PE 2018000014 A PE2018000014 A PE 2018000014A PE 2018000014 A PE2018000014 A PE 2018000014A PE 20180413 A1 PE20180413 A1 PE 20180413A1
Authority
PE
Peru
Prior art keywords
candida
endicrata
solid form
composition
probiotic bacterial
Prior art date
Application number
PE2018000014A
Other languages
English (en)
Inventor
Giovanni Mogna
Luca Mogna
Gian Paolo Strozzi
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Publication of PE20180413A1 publication Critical patent/PE20180413A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA EFERVESCENTE EN FORMA SOLIDA QUE COMPRENDE: A) UN SISTEMA ACIDO-BASE QUE CONTIENE UN ACIDO ORGANICO TAL COMO ACIDO CITRICO Y UNA SAL DEL ANION DE CARBONATO O BICARBONATO TAL COMO CARBONATO DE SODIO, BICARBONATO DE POTASIO, ENTRE OTROS, EN UNA CANTIDAD DE 1 A 15% EN PESO DE LA COMPOSICION; B) UNA MEZCLA DE CELULOSA MICROCRISTALINA Y ARABINOGALACTANO EN UNA PROPORCION POR PESO DE 1:1 A 3:1; C) UNA CEPA BACTERIANA PROBIOTICA TAL COMO LACTOBACILLUS PLANTARUM, LACTOBACILLUS CASEI, BIFIDOBACTERIUM LONGUM, BIFIDOBACTERIUM BIFIDUM, ENTRE OTROS, QUE DISMINUYE O ELIMINA AGENTES PATOGENOS TALES COMO CANDIDA ALBICANS, CANDIDA GLABRATA, CANDIDA KRUSEI, ENTRE OTROS. DICHA COMPOSICION SE ENCUENTRA EN FORMA DE TABLETA, OVULO, PASTILLA O GRANULADOS SIENDO UTIL EN EL TRATAMIENTO DE INFECCIONES VAGINALES
PE2018000014A 2011-01-28 2012-01-24 Composicion efervescente en forma solida que comprende cepas bacterianas probioticas PE20180413A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2011A000107A IT1403661B1 (it) 2011-01-28 2011-01-28 Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
IT000316A ITMI20110316A1 (it) 2011-01-28 2011-03-01 Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.

Publications (1)

Publication Number Publication Date
PE20180413A1 true PE20180413A1 (es) 2018-03-01

Family

ID=43975441

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2013001708A PE20140259A1 (es) 2011-01-28 2012-01-24 Composicion efervescente en forma solida para uso en aplicaciones vaginales para el tratamiento de infecciones vaginales
PE2018000014A PE20180413A1 (es) 2011-01-28 2012-01-24 Composicion efervescente en forma solida que comprende cepas bacterianas probioticas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PE2013001708A PE20140259A1 (es) 2011-01-28 2012-01-24 Composicion efervescente en forma solida para uso en aplicaciones vaginales para el tratamiento de infecciones vaginales

Country Status (22)

Country Link
US (2) US9492377B2 (es)
EP (1) EP2667849B1 (es)
JP (1) JP5992446B2 (es)
KR (1) KR101913797B1 (es)
CN (1) CN104519866A (es)
AU (1) AU2012210296B2 (es)
BR (1) BR112013018953B1 (es)
CL (1) CL2013002148A1 (es)
CO (1) CO6771428A2 (es)
DK (1) DK2667849T3 (es)
EC (1) ECSP13012844A (es)
ES (1) ES2751416T3 (es)
IT (2) IT1403661B1 (es)
MA (1) MA34926B1 (es)
MX (1) MX347165B (es)
PE (2) PE20140259A1 (es)
PL (1) PL2667849T3 (es)
PT (1) PT2667849T (es)
RU (1) RU2587717C2 (es)
TN (1) TN2013000310A1 (es)
UA (1) UA114888C2 (es)
WO (1) WO2012101500A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
ITMI20130794A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
TWI643626B (zh) 2013-08-12 2018-12-11 西班牙商巨妮亞實驗室有限公司 作為益生菌之乳桿菌屬菌株
US10793847B2 (en) 2015-05-11 2020-10-06 Mybiotics Pharma Ltd. Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut
KR101980252B1 (ko) 2015-05-26 2019-05-21 (주)투라인스 질증 치료용 조성물
ITUB20153106A1 (it) * 2015-08-13 2017-02-13 Probiotical Spa Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne
AU2015410635B2 (en) * 2015-09-29 2021-08-19 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
CN105534948B (zh) * 2015-12-17 2019-05-03 内蒙古双奇药业股份有限公司 一种可常温保存的阴道用活菌制剂及其制备方法
ITUB20159330A1 (it) * 2015-12-22 2017-06-22 Roelmi Hpc S R L Composizioni probiotiche e loro uso
BE1023643B1 (nl) * 2016-03-21 2017-06-01 Yun NV Vaginale preparaten voor het onderhouden en / of herstellen van een gezonde vrouwelijke microbiota
MA45334A (fr) * 2016-03-24 2019-01-30 Probiotical Spa Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes
WO2017163216A1 (en) * 2016-03-24 2017-09-28 Probiotical S.P.A. Lactic acid bacterial composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, of concurrent fungal infections
CN109071665B (zh) * 2016-04-18 2022-11-01 塞德斯医疗公司 结合人cd40的激动性抗体及其用途
IL294171A (en) 2016-05-25 2022-08-01 Mybiotics Pharma Ltd Compounds and methods for microbiotic therapy
MX2019004238A (es) * 2016-10-13 2019-11-08 Catalent Uk Swindon Zydis Ltd Composiciones farmaceuticas liofilizadas para suministro vaginal.
CN106798755B (zh) * 2017-03-10 2020-09-15 山东神农医院管理有限公司 一种具有调理乳腺增生功能的益生菌组合物及其应用
CN106692204B (zh) * 2017-03-10 2020-05-22 泰安大凡神农生物有限公司 一种缓解或改善盆腔炎症的益生菌组合物及其制备方法
KR102014810B1 (ko) * 2017-09-04 2019-08-27 라임바이오파마 주식회사 질염 예방 및 치료용 조성물
TWI703991B (zh) * 2017-09-29 2020-09-11 榮華 曹 供給二氧化碳氣體的衛生用品
CN109846846A (zh) * 2018-12-20 2019-06-07 赛奈金生物科技(上海)有限公司 一种含益生菌的泡腾缓释剂及其制备方法和应用
IT201800020425A1 (it) 2018-12-20 2020-06-20 Univ Degli Studi Di Modena E Reggio Emilia Lattobacilli con attività antimicrobica
CN109740292A (zh) * 2019-01-30 2019-05-10 中国测绘科学研究院 一种基于多智能体的城市人口空间分布估算方法及装置
US11045507B2 (en) 2019-02-21 2021-06-29 Ewelina Sosnowska-Turek Bifidobacterium animalis AMT30 strain and the composition containing the strain of Bifidobacterium animalis AMT30
KR102063757B1 (ko) * 2019-05-03 2020-01-08 주식회사 메디오젠 가드네렐라 바기날리스 및 칸디다 알비칸스에 항균 효과를 갖는 질염 치료 또는 개선용 유산균
CN110547915A (zh) * 2019-08-29 2019-12-10 云南白药清逸堂实业有限公司 应用益生菌的卫生棉制品及其制备方法
CN111647525B (zh) * 2020-05-18 2022-08-05 深圳华大基因农业控股有限公司 复合益生菌、菌剂及其在制备防治白色念珠菌性阴道炎菌剂中的应用
KR102444746B1 (ko) * 2021-09-16 2022-09-19 일동바이오사이언스(주) 락토바실러스 카제이 idcc 3451을 포함하는 질염에 유용한 조성물
WO2023080764A1 (ko) * 2021-11-08 2023-05-11 주식회사 씨티씨바이오 질염 또는 요로감염증 유발 미생물에 항균활성을 지닌 유산균 및 그의 용도
CN114350576B (zh) * 2022-03-17 2022-06-07 烟台欣和企业食品有限公司 提高料酒抗风险能力的乳杆菌及其应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819838A (en) 1970-08-04 1974-06-25 Bush Boake Allen Ltd Encapsulated flavoring composition
JPS53121949A (en) 1977-03-31 1978-10-24 Yakult Honsha Kk Production of drink and food containing bifidobacterium cells
DE2757370A1 (de) 1977-12-22 1979-07-05 Bayer Ag Gasdichte kunststoff-aluminium-verbundfolien
CH637297A5 (fr) 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
JPS58152809A (ja) * 1982-03-05 1983-09-10 Eisai Co Ltd 安定な発泡性「膣」坐剤
US4670272A (en) 1985-11-08 1987-06-02 Frito-Lay, Inc. Thermostable creme
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
CA2245810A1 (en) * 1996-02-14 1997-08-21 The Procter & Gamble Company Urogenital and intestinal compositions
EP0845350A1 (de) 1996-11-29 1998-06-03 Alusuisse Technology & Management AG Kalt-verformbare Verbundfolie
EP1067945B1 (en) 1998-04-01 2006-01-04 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
PT956858E (pt) * 1998-04-30 2002-04-29 Renata Maria Anna Caval Vesely Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
RU2150268C1 (ru) 1998-12-25 2000-06-10 Быков Валерий Алексеевич Суппозиторий с лактобактериями для лечения дисбактериозов влагалища
IT1309427B1 (it) 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
CN1234373C (zh) * 2000-09-28 2006-01-04 信谊药厂 含嗜酸乳杆菌的药物制剂及制备方法
WO2004101770A1 (en) 2003-03-13 2004-11-25 Universite De Moncton (Bureau De Soutien A L'innovation) Antioxidant producing bacterium and uses thereof
US20040185032A1 (en) 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
WO2004089278A2 (en) * 2003-04-09 2004-10-21 Dolhay Klinika Egészségügyi Kft. Sexual hygienic composition
PT1675481E (pt) 2003-10-24 2009-01-02 Nutricia Nv Composição sinbiótica para bebés
DE50300325D1 (de) 2003-11-03 2005-03-31 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
GB0405406D0 (en) 2004-03-10 2004-04-21 Edko Pazarlama Tanitim Ltd Sti Anti-vaginitis compositions
EP1600060A1 (en) 2004-05-25 2005-11-30 Cognis IP Management GmbH Oral and/or topical compositions comprising prebiotics and fatty acid
DE602004027120D1 (de) 2004-05-25 2010-06-24 Cognis Ip Man Gmbh Orale und/oder topische Zubereitungen
ES2290762T3 (es) 2004-08-05 2008-02-16 Anidral S.R.L. Cepas bacterianas de bifidobacterium que producen acido folico, sus formulaciones y utilizacion.
US20060039973A1 (en) * 2004-08-19 2006-02-23 Mary Aldritt Effervescent composition including water soluble dietary fiber
EP1814995A2 (en) 2004-10-27 2007-08-08 North Carolina State University Lactobacillus acidophilus nucleic acids and uses thereof
KR100661032B1 (ko) 2005-04-19 2006-12-22 주식회사한국야쿠르트 간 기능 개선, 혈중 알코올 감소 및 항산화에 유효한조성물
WO2007100765A2 (en) 2006-02-28 2007-09-07 Childrens Memorial Hospital Lysozyme-modified probiotic components and uses thereof
RU2318523C2 (ru) 2006-03-13 2008-03-10 Лев Давидович Раснецов Средство антимикробного действия
WO2007125558A1 (en) 2006-05-03 2007-11-08 Anidral S.R.L. Symbiotic composition comprising non-digestible polysaccharides and bifidobacteria which metabolize them and its uses
ITMI20061841A1 (it) 2006-09-27 2008-03-28 Mofin S R L Colture liquide microbiche ad elevata stabilita' ed attivita' fermentativa
ITMI20062286A1 (it) * 2006-11-28 2008-05-29 Anidral Srl Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi
US20080175899A1 (en) 2007-01-19 2008-07-24 Ross Mairi R Formulation for promoting sinus health in nasal cavities
US20080187628A1 (en) 2007-02-02 2008-08-07 Champion Melinda L Water-Soluble, Quick-Dissolve Flavor Tablets
PL210465B1 (pl) 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
WO2008153377A1 (en) 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
DE102008023952A1 (de) 2008-05-16 2009-12-03 Alcan Technology & Management Ag Verpackungs-Deckfolie, Behältnis, Verpackung und Verpackungs-Produkt-Einheit
CN102124097B (zh) 2008-08-28 2013-11-06 科.汉森有限公司 细菌组合物
US9283252B2 (en) 2008-09-30 2016-03-15 Meiji Co., Ltd. Lactic acid bacterium having high oxalic acid decomposition ability
PL2403510T3 (pl) 2009-03-05 2020-06-29 Probiotical S.P.A. Szczepy bakteryjne o wysokiej aktywności przeciwzapalnej
IT1400821B1 (it) 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico
FI20095550A0 (fi) 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
IT1397566B1 (it) 2009-05-27 2013-01-16 Probiotical Spa Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
WO2011017040A1 (en) 2009-07-27 2011-02-10 Nestec S.A. Nutritional compositions comprising fiber and probiotics
WO2011012932A1 (en) 2009-07-30 2011-02-03 Compagnie Gervais Danone Use of coated sterol or stanol particles for the preparation of food compositions having a low fat content and being essentially emulsifier-free
IT1398553B1 (it) 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
UA107711C2 (en) 2010-06-28 2015-02-10 Probiotical Spa Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITRM20110475A1 (it) 2011-09-09 2013-03-10 Probiotical Spa Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell

Also Published As

Publication number Publication date
PT2667849T (pt) 2019-10-29
CN104519866A (zh) 2015-04-15
EP2667849B1 (en) 2019-07-24
CL2013002148A1 (es) 2014-05-16
CO6771428A2 (es) 2013-10-15
ITMI20110316A1 (it) 2012-07-29
PE20140259A1 (es) 2014-03-08
MA34926B1 (fr) 2014-02-01
EP2667849A1 (en) 2013-12-04
MX347165B (es) 2017-04-18
JP2014503581A (ja) 2014-02-13
DK2667849T3 (da) 2019-10-28
TN2013000310A1 (en) 2015-01-20
IT1403661B1 (it) 2013-10-31
NZ614002A (en) 2015-11-27
ITMI20110107A1 (it) 2012-07-29
RU2587717C2 (ru) 2016-06-20
KR101913797B1 (ko) 2018-11-01
RU2013137656A (ru) 2015-03-10
BR112013018953A2 (pt) 2017-07-11
KR20140029392A (ko) 2014-03-10
WO2012101500A1 (en) 2012-08-02
ECSP13012844A (es) 2015-02-28
US20140065115A1 (en) 2014-03-06
AU2012210296B2 (en) 2017-01-05
UA114888C2 (uk) 2017-08-28
AU2012210296A1 (en) 2013-08-22
US9492377B2 (en) 2016-11-15
BR112013018953B1 (pt) 2020-12-29
JP5992446B2 (ja) 2016-09-14
ES2751416T3 (es) 2020-03-31
US20170014335A1 (en) 2017-01-19
MX2013008547A (es) 2013-12-02
PL2667849T3 (pl) 2020-06-15

Similar Documents

Publication Publication Date Title
PE20180413A1 (es) Composicion efervescente en forma solida que comprende cepas bacterianas probioticas
PE20140978A1 (es) Composicion farmaceutica solida que contiene amlodipina y losartan y el proceso para producirla
PH12014502778A1 (en) Antibody formulation
PE20121517A1 (es) Compuestos lipopeptidos y metodos relacionados
IN2014DN10260A (es)
PE20160048A1 (es) Composiciones antibioticas de ceftolozano
EA201690218A1 (ru) Штамм lactobacillus pentosus в качестве пробиотика
NZ718514A (en) Compounds, compositions and methods useful for cholesterol mobilisation
PE20121257A1 (es) Composicion higienizante
RU2015103115A (ru) Применение тиосульфата для усиления антипатогенного действия лактобацилл
PE20140337A1 (es) Nuevas formas cristalinas de la sal sodica del acido (4-{4-[5-(6-trifluoro-metil-piridin-3-il-amino)-piridin-2-il]-fenil}-ciclhexil)-acetico
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
PE20130374A1 (es) Composicion farmaceutica que comprende ibuprofeno
WO2012007913A3 (en) Oral administration forms for controlled release of rifampicin or other antibiotics for the treatment of bacterial infections and inflammatory diseases of the gastrointestinal tract
PE20140962A1 (es) Una formulacion farmaceutica solida
MY157492A (en) Pharmaceutical composition 271
MX356373B (es) Composiciones que comprenden un agente antibacterial y tazobactam.
IN2013MU02911A (es)
MX2012013178A (es) Composicion antiparasitaria de amplio espectro de nitazoxanida, probioticos y prebioticos.
WO2011093831A3 (en) Effervescent formulations comprising cefprozil as active agent
TN2015000156A1 (en) Dispersible tablet
PE20121819A1 (es) Composiciones y metodos para tratar infecciones bacterianas utilizando ceftarolina
BR112014002911A2 (pt) linhagem de l. bulgaricus capaz de inibir a adesão de linhagens de h. pylori a células epiteliais
PE20091372A1 (es) Polvo para suspension oral de un macrolido inmunosupresor
PE20142080A1 (es) Composiciones que contienen maltotriosa y formas de uso de la misma para inhibir el dano causado por el proceso de deshidratacion

Legal Events

Date Code Title Description
FD Application declared void or lapsed